Lucid Diagnostics Inc. (LUCD) Stock Grade

About Lucid Diagnostics Inc.'s fundamentals

Lucid Diagnostics is a healthcare medical device company with a market capitalization of $111.1 million that achieved 8.3% year-over-year revenue growth in its latest reporting period. However, the company reported a significant net loss, resulting in a net margin of -1232.7%, indicating it is currently unprofitable by a substantial margin. The company does not pay dividends, and traditional profitability metrics like P/E ratio and return on equity are not applicable given the loss position. This profile is typical of earlier-stage medical device companies that are investing heavily in development and commercialization ahead of profitability.